Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Gainers

Evelo Biosciences, Inc. (NASDAQ:EVLO) gained 115.4% to $0.2154 in pre-market trading. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.
Atomera Incorporated (NASDAQ:ATOM) shares climbed 33.7% to $6.98 in pre-market trading after the company posted a wider-than-expected quarterly loss. The company announced the execution of a commercial license agreement with STMicroelectronics (ST) that enables the latter to install Atomera's Mears Silicon Technology into its facilities.
OpGen, Inc. (NASDAQ:OPGN) gained 39.8% to $1.16 in pre-market trading after the company said its German subsidiary Curetis GmbH has met the remaining key milestones under the initial research and development collaboration agreement with FIND.
Mangoceuticals, Inc (NASDAQ:MGRX) surged 20.7% to $1.46 in pre-market trading after dropping around 33% on Wednesday. Mangoceuticals recently commenced online sales campaign with DojoLabs Group.
Immix Biopharma, Inc. (NASDAQ:IMMX) gained 14.1% to $2.11 in pre-market trading after Nexcella, an Immix Biopharma subsidiary, disclosed positive 58-patient NXC-201 clinical data.
U Power Limited (NASDAQ:UCAR) jumped 14% to $4.64 in pre-market trading after declining around 27% on Wednesday.
Ideanomics, Inc. (NASDAQ:IDEX) climbed 12.7% to $0.0309 in pre-market trading after dropping around 22% on Wednesday.
Meta Platforms, Inc. (NASDAQ:META) gained 11.3% to $233.00 in pre-market trading as the company reported better-than-expected Q1 results and also announced an increase in active users.
Edgio, Inc (NASDAQ:EGIO) gained 10.6% to $0.69 in pre-market trading.
Getaround, Inc. (NYSE:GETR) climbed 10.5% to $0.5026 in pre-market trading. Getaround received continued listing standard notice from NYSE related to delayed filing of Form 10-K.

Losers

Now Read This: Fear & Greed Index Moves To 'Neutral' Zone After Dow Drops Over 200 Points

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Gainers

Evelo Biosciences, Inc. (NASDAQ:EVLO) gained 115.4% to $0.2154 in pre-market trading. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.
Atomera Incorporated (NASDAQ:ATOM) shares climbed 33.7% to $6.98 in pre-market trading after the company posted a wider-than-expected quarterly loss. The company announced the execution of a commercial license agreement with STMicroelectronics (ST) that enables the latter to install Atomera's Mears Silicon Technology into its facilities.
OpGen, Inc. (NASDAQ:OPGN) gained 39.8% to $1.16 in pre-market trading after the company said its German subsidiary Curetis GmbH has met the remaining key milestones under the initial research and development collaboration agreement with FIND.
Mangoceuticals, Inc (NASDAQ:MGRX) surged 20.7% to $1.46 in pre-market trading after dropping around 33% on Wednesday. Mangoceuticals recently commenced online sales campaign with DojoLabs Group.
Immix Biopharma, Inc. (NASDAQ:IMMX) gained 14.1% to $2.11 in pre-market trading after Nexcella, an Immix Biopharma subsidiary, disclosed positive 58-patient NXC-201 clinical data.
U Power Limited (NASDAQ:UCAR) jumped 14% to $4.64 in pre-market trading after declining around 27% on Wednesday.
Ideanomics, Inc. (NASDAQ:IDEX) climbed 12.7% to $0.0309 in pre-market trading after dropping around 22% on Wednesday.
Meta Platforms, Inc. (NASDAQ:META) gained 11.3% to $233.00 in pre-market trading as the company reported better-than-expected Q1 results and also announced an increase in active users.
Edgio, Inc (NASDAQ:EGIO) gained 10.6% to $0.69 in pre-market trading.
Getaround, Inc. (NYSE:GETR) climbed 10.5% to $0.5026 in pre-market trading. Getaround received continued listing standard notice from NYSE related to delayed filing of Form 10-K.

Losers

Baudax Bio, Inc. (NASDAQ:BXRX) fell 52.3% to $0.8430 in pre-market trading after the company reported the pricing of $4 million public offering.
Impinj, Inc. (NASDAQ:PI) fell 24.1% to $102.70 in pre-market trading after the company reported mixed Q1 results and issued weak guidance.
Clearmind Medicine Inc. (NASDAQ:CMND) fell 13.5% to $0.6010 in pre-market trading. CONMED said it sees FY23 EPS of $3.30 to $3.50 and revenue of $1.205 billion to $1.250 billion.
Wolfspeed, Inc. (NYSE:WOLF) fell 13.3% to $49.79 in pre-market after the company issued weak Q4 guidance.
ETAO International Co., Ltd. (NASDAQ:ETAO) shares dropped 13.3% to $1.02 in pre-market trading after gaining around 57% on Wednesday.
Vornado Realty Trust (NYSE:VNO) fell 13% to $12.99 in pre-market trading. Vornado reported postponement of common share dividends until year-end and authorization of $200 million share repurchase program. Piper Sandler downgraded Vornado Realty from Neutral to Underweight and lowered the price target from $16 to $11.
Mobiquity Technologies, Inc. (NASDAQ:MOBQ) fell 11.8% to $0.1653 in pre-market trading after jumping 22% on Wednesday. Mobility Technologies recently announced its AI-powered ad targeting technology.
IN8bio, Inc. (NASDAQ:INAB) fell 11.3% to $1.73 in pre-market trading. IN8bio announced oral presentation of new INB-200 Phase 1 data in glioblastoma to be presented at 2023 ASCO Annual Meeting.
American Rebel Holdings, Inc. (NASDAQ:AREB) shares fell 10% to $0.1386 in pre-market trading after gaining around 14% on Wednesday.
Windtree Therapeutics, Inc. (NASDAQ:WINT) fell 8% to $1.62 in pre-market trading. Windtree Therapeutics recently announced closing of $12.42 million underwritten public offering including full exercise of overallotment option.